Bank of New York Mellon Corp Grows Position in National Research Co. (NASDAQ:NRC)

Bank of New York Mellon Corp increased its position in shares of National Research Co. (NASDAQ:NRC) by 88.5% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 217,212 shares of the company’s stock after buying an additional 101,957 shares during the period. Bank of New York Mellon Corp owned about 0.93% of National Research worth $3,832,000 at the end of the most recent reporting period.

Other large investors have also recently made changes to their positions in the company. FMR LLC increased its stake in shares of National Research by 397.3% during the third quarter. FMR LLC now owns 2,944 shares of the company’s stock worth $67,000 after buying an additional 2,352 shares during the period. Point72 Asset Management L.P. purchased a new stake in shares of National Research during the third quarter worth approximately $88,000. Point72 Asia Singapore Pte. Ltd. purchased a new stake in shares of National Research during the third quarter worth approximately $96,000. Meeder Asset Management Inc. purchased a new stake in shares of National Research during the third quarter worth approximately $159,000. Finally, SG Americas Securities LLC increased its stake in shares of National Research by 35.0% during the fourth quarter. SG Americas Securities LLC now owns 7,298 shares of the company’s stock worth $129,000 after buying an additional 1,893 shares during the period. 47.26% of the stock is currently owned by hedge funds and other institutional investors.

National Research Stock Up 3.2 %

NRC stock opened at $15.55 on Wednesday. The company’s 50 day moving average price is $16.36 and its 200 day moving average price is $18.44. The company has a debt-to-equity ratio of 1.30, a quick ratio of 0.47 and a current ratio of 0.47. National Research Co. has a fifty-two week low of $13.74 and a fifty-two week high of $40.69. The firm has a market capitalization of $365.05 million, a price-to-earnings ratio of 14.81 and a beta of 0.47.

National Research (NASDAQ:NRC) last announced its quarterly earnings results on Monday, January 27th. The company reported $0.28 EPS for the quarter. National Research had a net margin of 17.32% and a return on equity of 66.52%.

National Research Company Profile

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.